Galmed Pharmaceuticals Provides Business Updates and Reports First Quarter 2021 Financial Results

Go back to Galmed Pharmaceuticals Provides Business Updates and Reports First Quarter 2021 Financial Results

Galmed Pharma (GLMD) Reports In-Line Q1 EPS

May 13, 2021 7:52 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.38), in-line with the analyst estimate of ($0.38).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More